Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recombinant human growth hormone for short stature due to chronic kidney disease before transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Leading to Short Stature in Children
• Dwarfism

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Dwarfism | Phase 3 | Status: UNKNOWN